EV-miR-23a from hypoxic lung cancer cells increases tube formation, permeability and cancer cell transendothelial invasion of normoxic and hypoxic HUVECs by targeting PHD1, PHD2 and ZO-1, thereby promoting neovascularization and tumor growth in vivo [217]. This evidence concerns the gene TJP1 and cancer.